Glenmark Pharmaceuticals Inc.,Usa

Name: Glenmark Pharmaceuticals Inc.,Usa | See Full Importer History | ImportGenius
Creator: ImportGenius
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

US Customs records for Glenmark Pharmaceuticals Inc.,Usa in Monroe. See their past imports and exports, including shipments from Prefect Packaging Private Limited, a supplier based in India.

Call ImportGenius Sales

Join ImportGenius to see the import/export activity of every company in the United States. Track your competitors, get freight forwarding leads, enforce exclusivity agreements, learn more about your overseas factories, and much more. Instant signup.

Get United States data for $199

Total Shipments

3,012

Trading Partners

Top Partner

GLENMARK PHARMACEUTICALS LIMITED

Ports

Top Port

Nhava Sheva

Contact Info

Glenmark Pharmaceuticals Inc.,Usa

4147 Goldmine Road Monroe Nc 28110 Us

Glenmark Pharmaceuticals Inc.,Usa Records

Get a complete importer history

Updated: 2025-10-14

Total shipments from 2006-11-01 to 2025-10-14

Precise data and chart data points are only available to paid subscribers

Importer Shipments

Top Trading Partners

Legend

Top Ports

Legend

Nhava Sheva
Salalah
Mundra
Colombo
Bremerhaven

Total shipments from 2006-11-01 to 2025-10-14

Precise data and chart data points are only available to paid subscribers

Importer Shipments

#	Bill of Lading	Product	Importer	Supplier	Arrival Date	Country of Origin	Gross Weight KGS	Quantity
1	FRNKFMC082504655	HS CODE BOXES OF NON-CORRUGATED PAPER AND PAPER BOARD FULVESTRANT MONR	GLENMARK PHARMACEUTICALS INC USA	PREFECT PACKAGING PRIVATE LIMITED	2025-10-14	Oman	2216 Kgs	167 PKG
2	MAEU254068328	40 PACKAGES 2188 CARTONS PHA RMACEUTICALS AS UNDER VAREN ICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-894-56 FDA PRODU CT CODE : 65ZCA01 ANDA NO. : 214255 HTS NO 3004.90.99 TH ERAPEUTIC USE : USE AS AN AID, TO SMOKING CESSATION TREATMEN T VARENICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-894-56 FDA PRODUCT CODE : 65ZCA01 A NDA NO. : 214255 HTS NO 3004 .90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSATIO N TREATMENT VARENICLINE TABLETS 0.5 MG & 1MG , (STARTING MONTH BOX) NDC NO. : 68462-89 5-04 FDA PRODUCT CODE : 65ZCA 01 ANDA NO. : 214255 HTS NO 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CES SATION TREATMENT VARENICLIN E TABLETS 0.5 MG & 1MG , (STARTING MONTH BOX) NDC NO. : 684 62-895-04 FDA PRODUCT CODE : 65ZCA01 ANDA NO. : 214255 HT S NO 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKIN G CESSATION TREATMENT COMME RCIAL & CUSTOM INVOICE NO. 83 2436449 DTD 23.05.2025 S/BILL NO: 2099137 DT 23-MAY-2025 G ROSS WT. 5,073.800 KGS NET WT .533.070 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	MANKIND PHARMA LTD	2025-07-01	India	5084 Kgs	40 PKG
3	MAEU253901512	49 PACKAGES 2614 CARTONS PHA RMACEUTICALS AS UNDER CARVE DILOL TAB 25MG 500 NDC CODE:6 8462016505 FDA PRODUCT CODE N O :62 O C A 22 HTS NO.3004.9 0.9221 ANDA NO.78-251 THERAP EUTICE USE:-BETA- ADRENOACEP, TOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:684 62039710 FDA PRODUCT CODE NO .:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 150MG 100 NDC CODE:68462013701 FDA P RODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT PRAMIP EXOLE TAB 1MG 90 NDC CODE:684 62033390 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.:3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE DROSPIR ENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO .: 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PR EGNANCY OMEPRAZOLE DR CAP 4 0MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF1 0 HTS NO.3004.90.9255 ANDA N O.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 150MG 100 NDC C ODE:68462013701 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT PRAMIPEXOLE TA B 1MG 90 NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 JC A 15 H. T. S NO.: 3004.90. 92.40 ANDA NO.: 90-781 THERA PEUTICE USE: USED IN PARKINSO N#S DISEASE INDOMETHACIN CA P 25MG 100 NDC CODE:684620406 01 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:91-276 THERAPEUTICE USE: -ANTI-INFLAMATO RY COMMERCIAL & CUSTOM IN VOICE NO. F22652000806 DT. 17 .05.2025 F22652000808 DT. 17. 05.2025 F22652000807 DT. 17.0 5.2025 F22652000818 DT. 18.05 .2025 F22652000819 DT. 18.05. 2025 S/BILL NO: 1941558 DT 19-MAY-2025 S/BILL NO: 1941911 DT 19-MAY-2025 S/BILL NO: 194 6821 DT 19-MAY-2025 S/BILL NO : 1941571 DT 19-MAY-2025 S/BI LL NO: 1944952 DT 19-MAY-2025 GROSS WT. 10,520.723 KGS N ET WT.8883.685 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-23	Oman	10543 Kgs	49 PKG
4	MAEU253741885	28 PACKAGES 1972 CARTONS PHA RMACEUTICALS AS UNDER PRAMI PEXOLE TAB 0.25MG 90 NDC CODE :68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED, IN PARKINSON#S DISEASE. CA RVEDILOL TAB 25MG 500 NDC COD E:68462016505 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST ZONISAMI DE CAP 100MG 100 NDC CODE:68462013001 FDA PRODUCT CODE NO .:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-65 1 THERAPEUTICE USE:-ANTISEIZ URE DRUG CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDANO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST HEATHER TAB 0.35MG 84 N DC CODE:68462030329 FDA PRODU CT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTION OF PREGNANCY.COMMERCIAL & CUSTOM INVOICE NO . F22652000766 DT. 16.05.2025 F22652000767 DT. 16.05.2025 F22652000782 DT. 16.05.2025 F22652000783 DT. 16.05.2025 F 22652000780 DT. 16.05.2025 S/ BILL NO: 1920008 DT 17-MAY-202 5 S/BILL NO: 1921515 DT 17-MAY-2025 S/BILL NO: 1919793 DT 17-MAY-2025 S/BILL NO: 192211 6 DT 17-MAY-2025 S/BILL NO: 1 917344 DT 17-MAY-2025 GROSS WT. 6,613.151 KGS NET WT.545 3.873 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-23	Oman	6627 Kgs	28 PKG
5	MAEU254037875	PART OF FCL 1 PACKAGES 20 CARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING T AB 0.6MG 100 NDC CODE:6846206 4001 FDA PRODUCT CODE NO.:66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER, APEUTICE USE: :#MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T COMMERCIAL & CUSTOM INVO ICE NO. F22687000272 DT. 14.0 5.2025 S/BILL NO: 1854090 DT:15-MAY-25 GROSS WT. 117.149 K GS NET WT.10.570 KGS 01 DATA LOGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-23	Oman	117 Kgs	1 PKG
6	MAEU253901504	PART OF FCL 42 PACKAGES 17 54 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINTMENT 0.03% 60GM NDC CODE:684620881 65 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO.: 3004.49 .0050 ANDA NO.:210393 THERAP, EUTICE USE: TOPICAL IMMUNOSU PPRESSIVE AGENT CLINDAMYCI N HCL CAP 300MG 100 NDC CODE: 68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.:21695 7 THERAPEUTICE USE: :#TREATM ENT OF NUMEROUS INFECTIONS, INCLUDING BUT NOT LIMITED TO SEPTICEMIA,INTRAABDOMINAL IN FECTIONS, LOWER RESPIRATORY INFECTIONS, GYNECOLOGICAL INF ECTIONS, BONE AND JOINT INFEC TIONS, AND SKIN AND SKIN STRU CTURE INFECTIONS COLESEVEL AM HCL TAB 625MG 180 NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 03480 THERAPEUTICE USE: - AN TIHYPERLIPO PROTEINEMIC. G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT COMMERCIAL & CUSTOM I NVOICE NO. F22687000269 DT. 1 4.05.2025 F22687000270 DT. 14 .05.2025 F22687000271 DT. 14. 05.2025 S/BILL NO:1854088 DT: 15-MAY-25 S/BILL NO:1854100DT:15-MAY-25 S/BILL NO:185410 4 DT:15-MAY-25 GROSS WT. 9,09 6.838 KGS NET WT.5784.823 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-23	Oman	9116 Kgs	42 PKG
7	MAEU253901144	44 PACKAGES 3026 CARTONS PHA RMACEUTICALS AS UNDER ONDAN SETRON ODT 4MG 30UD NDC CODE: 68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -152 THERAPEUTICE USE:-ANTI, -EMETIC PRAMIPEXOLE TAB 0.2 5MG 90 NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92 .40 ANDA NO.: 90-781 THERAPE UTICE USE: USED IN PARKINSON# S DISEASE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.:62KC F10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE OM EPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THE RAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUST OM INVOICE NO. F22652000795 D T. 17.05.2025 F22652000787 DT . 17.05.2025 F22652000804 DT. 17.05.2025 S/BILL NO: 1923246 DT 17-MAY-2025 S/BILL NO: 1 922769 DT 17-MAY-2025 S/BILL NO: 1944089 DT 19-MAY-2025 GR OSS WT. 8,581.297 KGS NET WT. 6617.226 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-23	Oman	8599 Kgs	44 PKG
8	MAEU253546369	40 PACKAGES 1951 CARTONS PHA RMACEUTICALS AS UNDER NORET H ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO. :206969 THERAPEUTICE USE: -, SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTO M INVOICE NO. F22652000707 DT . 12.05.2025 S/BILL NO: 17282 85 DT 12-MAY-2025 GROSS WT. 5 ,700.500 KGS NET WT.4131.460 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-17	India	5712 Kgs	40 PKG
9	MAEU253546364	PART OF FCL 30 PACKAGES 1 831 CARTONS PHARMACEUTICALS A S UNDER ALYACEN 777 TAB 0.5 ,0.75,1/0.035MG 84 NDC CODE:6 8462055629 FDA PRODUCT CODE N O.: 65 J D A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.: 091, 636 THERAPEUTICE USE: ORAL C ONTRACEPTIVE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039 790 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE ATOMOXETINE CAP 80MG 30 NDC CO DE:68462027030 FDA PRODUCT CO DE NO.: 64 UCA 99 H. T. S N O.:3004.90.92.90 ANDA NO.: 07 9019 THERAPEUTICE USE: - ATO MOXETINE IS USED TO TREAT ATT ENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF ATOTAL TREATMENT PLAN, INCLUDI NG PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS COMMER CIAL & CUSTOM INVOICE NO. F22 652000658 DT. 08.05.2025 F226 52000657 DT. 08.05.2025 F2265 2000659 DT. 08.05.2025 S/BILL NO: 1641934 DT:08-MAY-25 S/BILL NO: 1641931 DT 08-MAY-2025 S/BILL NO: 1641935 DT 08-MAY -2025 GROSS WT. 6,771.950 K GS NET WT.5366.310 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2025-06-17	India	6786 Kgs	30 PKG
10	COSU6417417471	FAMOTIDINE TABLETS	GLENMARK PHARMACEUTICALS INC., USA	VKT PHARMA PRIVATE LIMITED	2025-06-11	India	1792 Kgs	10 PKG

#	Importer	Last Address	Most Recent

#	Supplier	Last Address	Most Recent	No. of Containers	Gross Weight KGS
1	GLENMARK PHARMACEUTICALS LIMITED	India	2025-06-23	2880	16872448
2	GLENMARK GENERICS LTD	India	2019-05-01	14	78248
3	ENCUBE ETHICALS PVT LTD	India	2018-12-24	12	97265
4	N/A	India	2018-09-20	10	67202
5	SHRIJI POLYMERS INDIA LIMITED	India	2021-03-23	11	12855

More data available to paid subscribers

Sample Shipment From Glenmark Pharmaceuticals Inc.,Usa

Bill of Lading FRNKFMC082504655

Arrival Date: 2025-10-14

Container Number: HASU5198410

Cargo #1
Description HS CODE BOXES OF NON-CORRUGATED PAPE R AND PAPER BOARD FULVESTRANT MONR
Keywords code boxes non corrugated pape r paper board fulvestrant monr	HS-Code DATA UNAVAILABLE	Piece Count 167

Length DATA UNAVAILABLE	Height DATA UNAVAILABLE
Width DATA UNAVAILABLE	Load Status Loaded
Seal 5288792, IN2530564	Equipment Description AC
Type DATA UNAVAILABLE	Type of Service Pier to Pier
Container Type DATA UNAVAILABLE	Marks & Numbers GLENMARK PHARMACEUTICALS INC USA

Carrier FRANCK TRUCKING	Carrier Code FRNK
Carrier Address PO BOX 524	Carrier Contact Number DATA UNAVAILABLE
Ship Registered In DATA UNAVAILABLE	Foreign Port MINA RAYSUT
Voyage Number 536W	Country of Origin INDIA
Vessel Name MAERSK ATLANTA	U.S. Port DATA UNAVAILABLE
Master Bill of Lading MAEU258513547	Weight (LB/KG) 4886.28 / 2216
Quantity 167 PKG	Container Count 1
Place of Receipt AHMEDABAD INDIA	Distribution Port DATA UNAVAILABLE
House-v-Master DATA UNAVAILABLE	Measurement DATA UNAVAILABLE
In-Bond Entry-Type DATA UNAVAILABLE	Bill Type Code House Bill